Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Assets (2023 - 2025)

Historic Return on Assets for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 1.06%.

  • Mangoceuticals' Return on Assets fell 4400.0% to 1.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.06%, marking a year-over-year decrease of 4400.0%. This contributed to the annual value of 1.06% for FY2024, which is N/A changed from last year.
  • Mangoceuticals' Return on Assets amounted to 1.06% in Q3 2025, which was down 4400.0% from 0.67% recorded in Q2 2025.
  • Mangoceuticals' 5-year Return on Assets high stood at 0.58% for Q4 2024, and its period low was 13.34% during Q1 2024.
  • In the last 3 years, Mangoceuticals' Return on Assets had a median value of 0.86% in 2025 and averaged 3.13%.
  • Within the past 5 years, the most significant YoY rise in Mangoceuticals' Return on Assets was 127400bps (2025), while the steepest drop was -4400bps (2025).
  • Mangoceuticals' Return on Assets (Quarter) stood at 6.96% in 2023, then skyrocketed by 92bps to 0.58% in 2024, then crashed by -84bps to 1.06% in 2025.
  • Its Return on Assets stands at 1.06% for Q3 2025, versus 0.67% for Q2 2025 and 0.6% for Q1 2025.